Congenital heart defectsare the most common birth defects in the world1-2.
1.35 million babies worldwide are born with congenital heart disease every year1-2.
Nearly 25 % of babies with a congenital heart defect require surgery during their first year3.
93 % of these children have no access to care2-4.
As a global healthcare company, Abbott is committed to the research and development of life-changing technologies for newborns and children with heart problems. We partner with organizations and physicians dedicated to giving these children the best possible treatment.
With Little Heroes, Abbott supports children with congenital heart defects in developing countries, where there is no access to healthcare. Abbott provides life-changing technologies and additional support for children that do not have access to healthcare. With this program Abbott wants to give these children the chance to grow up and reach their full potential.
They are little and heroes already. They do not surrender and neither do we. Supporting them and their families with life-changing technologies is part of our commitment to helping kids thrive, along with creating medical solutions that save and improve their lives. With our technological innovation, clinical leadership and community partnerships we are proud to shine a spotlight on congenital heart disease.
Watch our Little Heroes movie.
Baby Sadie received the world’s smallest mechanical heart valve, and her life instantly changed.
Sadie Rutenberg is a little girl who likes the color pink and loves penguins. She's happy, spunky and very friendly. But Sadie isn't like most children her age — she was the first child in the United States to receive a revolutionary pediatric mechanical heart valve when she was a baby.
Learn more about Sadie’s inspiring story here.
If you have any questions or comments about this website, please address them to: info@little-heartheroes.com